AMRN FY 2015 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$338M

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$82M+50.8% YoY

Gross Profit

$54M65.9% margin

Operating Income

-$98M-120.1% margin

Net Income

-$115M-140.9% margin

EPS (Diluted)

$-16.60

Cash Flow

Operating Cash Flow

-$85M

Free Cash Flow

-$85M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$173M

Total Liabilities

$303M

Stockholders' Equity

-$129M

Cash & Equivalents

$107M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$82M	$54M	+50.8%
Gross Profit	$54M	$34M	+59.8%
Operating Income	-$98M	-$96M	-2.4%
Net Income	-$115M	-$56M	-104.4%